文献速递心外重症与机械循环支持先天性心脏病外科

MELD-XI评分对儿童VAD植入后生存的预测价值

Significance of pre and post-implant MELD-XI score on survival in children undergoing VAD implantation.
PubMed 文献 · J Heart Lung Transplant · 2021-08-30

基于Pedimacs数据库2012至2019年742例儿童VAD植入患者,评估植入前及植入后1周MELD-XI评分对预后的预测作用。高MELD-XI评分(>13.6)患者生存更差,出血、肾功能不全和呼吸衰竭更多。MELD-XI评分是比胆红素或肌酐单独更好的死亡预测指标。

要点

  • 植入前MELD-XI>13.6的儿童VAD患者生存更差、并发症更多
  • MELD-XI每升高1单位死亡风险HR 1.1,优于胆红素或肌酐单独预测
  • 植入后早期MELD-XI持续升高或维持高值的患者生存最差

核心结论

  • MELD-XI是易于计算的评分,可作为识别儿童VAD植入后不良结局风险的有前景评估工具。

研究设计与样本

  • 回顾性队列研究,查询Pedimacs数据库2012年9月19日至2019年12月31日所有儿童VAD植入患者,共742例有可计算植入前MELD-XI评分。

主要发现

  • 高MELD-XI评分(>13.6)队列较中、低评分队列生存更差,植入后出血、肾功能不全和呼吸衰竭增加。
  • 死亡危险因素包括MELD-XI评分升高(每1单位HR 1.1)、Pedimacs profile 1(HR 1.6)、先天性心脏病(HR 2.3)和使用经皮VAD(HR 2.7)。
  • MELD-XI评分比胆红素或肌酐单独更能预测VAD植入后死亡,后两者在最终模型中均不显著。
  • 植入后早期MELD-XI升高或持续高值者生存最差。

关键数值与推荐

  • 植入前高MELD-XI评分定义为评分>13.6。
  • 多相参数风险模型用于识别植入后死亡的独立预测因素。

临床怎么用

  • 可计算儿童VAD候选者的植入前及植入后早期MELD-XI评分,用于风险分层和识别高危患儿。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Derangements in liver and renal function often accompany end-stage heart failure. We sought to assess the utility of an objective risk assessment tool, the Model for End-stage Liver Disease eXcluding INR (MELD-XI), to identify pediatric patients at increased risk for adverse outcomes post-ventricular assist device (VAD) implantation. METHODS: The Pedimacs database was queried for all pediatric patients who underwent VAD implantation from September 19, 2012 to December 31, 2019. Pre-implant and early (1-week) post-implant MELD-XI scores were used to stratify patients into low, intermediate and high score cohorts. Comparison of pre-implant characteristics and post-implant outcomes were conducted across groups. Multiphase parametric hazard modeling was utilized to identify independent predictors of post-implant mortality. RESULTS: A total of 742 patients had a calculable MELD-XI score pre-implant. When stratified by MELD-XI scores pre-implant, patients in the high MELD-XI score cohort (score >13.6) had inferior survival and increased bleeding, renal dysfunction and respiratory failure post-implant compared to intermediate and low score cohorts. Risk factors for mortality post-VAD implantation were: increasing MELD-XI scores (HR 1.1 per 1 unit rise), Pedimacs profile 1 (HR 1.6), congenital heart disease (HR 2.3) and being on a percutaneous VAD (HR 2.7). Importantly, MELD-XI score was a better predictor of post-VAD implant mortality than bilirubin or creatinine alone, neither of which were significant in the final model. Patients with increasing or continued high MELD-XI scores early post-implant had the worst survival. CONCLUSION: The MELD-XI is an easily calculated score that serves as a promising risk assessment tool in identifying children at risk for poor outcomes post VAD implantation.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Amdani S, Boyle GJ, Cantor RS, et al. Significance of pre and post-implant MELD-XI score on survival in children undergoing VAD implantation. J Heart Lung Transplant. 2021. PMID: 34598872. doi:10.1016/j.healun.2021.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。